This is a Validated Antibody Database (VAD) review about human fascin, based on 21 published articles (read how Labome selects the articles), using fascin antibody in all methods. It is aimed to help Labome visitors find the most suited fascin antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
fascin synonym: FAN1; HSN; SNL; p55

Santa Cruz Biotechnology
mouse monoclonal (D-10)
  • western blot; mouse; fig 4e
Santa Cruz Biotechnology fascin antibody (Santa Cruz Biotechnology, sc-46675) was used in western blot on mouse samples (fig 4e). Genes Dev (2018) ncbi
mouse monoclonal (D-10)
  • western blot; human; fig 13a
Santa Cruz Biotechnology fascin antibody (Santa Cruz, D-10) was used in western blot on human samples (fig 13a). J Pineal Res (2018) ncbi
mouse monoclonal
  • western blot; human; fig 13a
Santa Cruz Biotechnology fascin antibody (Santa Cruz, D-10) was used in western blot on human samples (fig 13a). J Pineal Res (2018) ncbi
mouse monoclonal (SPM133)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 5
Santa Cruz Biotechnology fascin antibody (SantaCruz, sc-56531) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5). Oncotarget (2017) ncbi
mouse monoclonal (55K-2)
  • immunocytochemistry; mouse; 1:20; loading ...; fig s11
Santa Cruz Biotechnology fascin antibody (Santa Cruz, SC-21743) was used in immunocytochemistry on mouse samples at 1:20 (fig s11). Nat Commun (2017) ncbi
mouse monoclonal (D-10)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6F
  • western blot; human; 1:500; loading ...; fig 5C
Santa Cruz Biotechnology fascin antibody (Santa Cruz, sc-46675) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6F) and in western blot on human samples at 1:500 (fig 5C). Oncotarget (2017) ncbi
mouse monoclonal (SPM133)
  • immunohistochemistry - paraffin section; human; fig 2
Santa Cruz Biotechnology fascin antibody (Santa Cruz, SC-56531) was used in immunohistochemistry - paraffin section on human samples (fig 2). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (SPM133)
  • immunohistochemistry; human; fig 2
Santa Cruz Biotechnology fascin antibody (Santa Cruz, SC-56531) was used in immunohistochemistry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (D-10)
  • western blot; human; fig 4
Santa Cruz Biotechnology fascin antibody (Santa Cruz, sc-46675) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (5G112)
  • western blot; human
Santa Cruz Biotechnology fascin antibody (Santa Cruz, sc-71100) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi
mouse monoclonal (55K-2)
  • immunocytochemistry; human; 1:100
In order to evaluate diagnostic markers for lung cancer with bronchial brushing specimens, Santa Cruz Biotechnology fascin antibody (Santa Cruz Biotechnology, sc-21743) was used in immunocytochemistry on human samples at 1:100. Cancer Cytopathol (2014) ncbi
mouse monoclonal (55K-2)
  • western blot; human
Santa Cruz Biotechnology fascin antibody (Santa Cruz, sc-21743) was used in western blot on human samples . J Biol Chem (2013) ncbi
mouse monoclonal (55K-2)
  • western blot; mouse; loading ...; fig s1f
Santa Cruz Biotechnology fascin antibody (Santa, 55K2) was used in western blot on mouse samples (fig s1f). Curr Biol (2012) ncbi
Invitrogen
mouse monoclonal (FCN01 (55K-2))
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to study breast carcinoma in Egyptian women and poor prognosis if Fascin and matrix metalloproteinase-9 expression are associated, Invitrogen fascin antibody (Thermo Fisher Scientific, FCN01) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Diagn Pathol (2014) ncbi
Abcam
domestic rabbit monoclonal (EP5902)
  • flow cytometry; human
Abcam fascin antibody (Abcam, ab126772) was used in flow cytometry on human samples . Sci Rep (2015) ncbi
Dako
mouse monoclonal (55K-2)
  • western blot; human; 1:100; fig 2b
Dako fascin antibody (Dako, M3567) was used in western blot on human samples at 1:100 (fig 2b). Mol Med Rep (2016) ncbi
mouse monoclonal (55K-2)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
Dako fascin antibody (Dako, M3567) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (55K-2)
  • western blot; human; fig 5
In order to study cooperation in cancer cell invadopodia and filopodia by fascin rigidity and L-plastin flexibility, Dako fascin antibody (Dako, M356701) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
mouse monoclonal (55K-2)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to assess the prognostic value of an immunohistochemistry-based three-protein signature model in patients with esophageal squamous cell carcinoma, Dako fascin antibody (DAKO, M3567) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (55K-2)
  • immunohistochemistry - paraffin section; domestic sheep; 1:100
Dako fascin antibody (Dako Cytomation, 55K-2) was used in immunohistochemistry - paraffin section on domestic sheep samples at 1:100. Virchows Arch (2014) ncbi
mouse monoclonal (55K-2)
  • western blot; human; 1:100
Dako fascin antibody (Dako, M3567) was used in western blot on human samples at 1:100. Br J Cancer (2014) ncbi
Cell Signaling Technology
monoclonal (55K-2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1d
Cell Signaling Technology fascin antibody (cell signaling, 99978) was used in immunohistochemistry - paraffin section on human samples (fig 1d). BMC Cancer (2019) ncbi
Articles Reviewed
  1. Liang J, Liu Z, Wei X, Zhou L, Tang Y, Zhou C, et al. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients. BMC Cancer. 2019;19:1165 pubmed publisher
  2. Lafita Navarro M, Kim M, Borenstein Auerbach N, Venkateswaran N, Hao Y, Ray R, et al. The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells. Genes Dev. 2018;32:1303-1308 pubmed publisher
  3. Proietti S, Catizone A, Masiello M, Dinicola S, Fabrizi G, Minini M, et al. Increase in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation. J Pineal Res. 2018;64:e12467 pubmed publisher
  4. Ayars M, O Sullivan E, Macgregor Das A, Shindo K, Kim H, Borges M, et al. IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth. Oncotarget. 2017;8:83370-83383 pubmed publisher
  5. Kage F, Winterhoff M, Dimchev V, Mueller J, Thalheim T, Freise A, et al. FMNL formins boost lamellipodial force generation. Nat Commun. 2017;8:14832 pubmed publisher
  6. Wu Q, Yan H, Tao S, Wang X, Mou L, Chen P, et al. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p. Oncotarget. 2017;8:16784-16800 pubmed publisher
  7. Zeng F, Xie Y, Liao L, Li L, Chen B, Xie J, et al. Biological characterization of three immortalized esophageal epithelial cell lines. Mol Med Rep. 2016;14:4802-4810 pubmed publisher
  8. Rai V, Rao V, Shao Z, Agrawal D. Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis. PLoS ONE. 2016;11:e0154802 pubmed publisher
  9. Nuñez O, Román A, Johnson S, Inoue Y, Hirose M, Casanova Ã, et al. Study of breast cancer incidence in patients of lymphangioleiomyomatosis. Breast Cancer Res Treat. 2016;156:195-201 pubmed publisher
  10. Van Audenhove I, Denert M, Boucherie C, Pieters L, Cornelissen M, Gettemans J. Fascin Rigidity and L-plastin Flexibility Cooperate in Cancer Cell Invadopodia and Filopodia. J Biol Chem. 2016;291:9148-60 pubmed publisher
  11. Sellerio A, Ciusani E, Ben Moshe N, Coco S, Piccinini A, Myers C, et al. Overshoot during phenotypic switching of cancer cell populations. Sci Rep. 2015;5:15464 pubmed publisher
  12. Ruiz de Garibay G, Herranz C, Llorente A, Boni J, Serra Musach J, Mateo F, et al. Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness. PLoS ONE. 2015;10:e0132546 pubmed publisher
  13. Poli G, Ceni E, Armignacco R, Ercolino T, Canu L, Baroni G, et al. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma. Oncotarget. 2015;6:5695-706 pubmed
  14. Cao H, Zhang S, SHEN J, Wu Z, Wu J, Wang S, et al. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget. 2015;6:5435-48 pubmed
  15. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed publisher
  16. Liu Y, Jiang Y, Wang B, Hao J, Shang L, Zhang T, et al. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens. Cancer Cytopathol. 2014;122:833-41 pubmed publisher
  17. Youssef N, Hakim S. Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women. Diagn Pathol. 2014;9:136 pubmed publisher
  18. Miki Y, Hamada K, Yoshino T, Miyatani K, Takahashi K. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma. Virchows Arch. 2014;464:725-34 pubmed publisher
  19. Sun J, He H, Pillai S, Xiong Y, Challa S, Xu L, et al. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion. J Biol Chem. 2013;288:36971-82 pubmed publisher
  20. Akanuma N, Hoshino I, Akutsu Y, Murakami K, Isozaki Y, Maruyama T, et al. MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer. 2014;110:189-98 pubmed publisher
  21. Block J, Breitsprecher D, Kuhn S, Winterhoff M, Kage F, Geffers R, et al. FMNL2 drives actin-based protrusion and migration downstream of Cdc42. Curr Biol. 2012;22:1005-12 pubmed publisher